The College of Science and Mathematics’ Advisory Board provides guidance, support and advocacy for the College’s pedagogical, research and outreach programs. The Board assists the College in maintaining currency with changing educational, economic, national and international needs; helps to identify emerging directions for research and educational programs, as well as sources for student support, program and research collaboration, funding and other professional opportunities; and helps to promote the College with the external community.
Dr. Barbara Brummer ’68
Director, The Nature Conservancy of NJ
Elizabeth D. Kay Environment Center
Chair, Advisory Board
Dr. Barbara Brummer is the State Director at The Nature Conservancy of New Jersey where she is the key leader of the Conservancy’s program in New Jersey. A longstanding member of the Conservancy, Dr. Brummer was hired as State Director in January 2004. Prior to joining the Conservancy, she had retired from a successful career in the private sector, spending the last twelve years as an executive with Johnson & Johnson. Among her positions at J&J, she served as President of J&J Canada Inc. and Worldwide Vice President of the Women’s Health and Wellness Franchise. Throughout her career, Barbara has maintained a passionate interest in conservation. For many years, she taught a course in field biology at Montclair State University and has spent many hours seeking out natural areas and studying the flora of New Jersey. In addition to her longstanding membership in The Nature Conservancy, Barbara has also been active in other local conservation organizations, serving on the boards of the New Jersey Audubon Society, the Pocono Environmental Education Center and the Palisades Nature Association. Soon after joining The Nature Conservancy, she was appointed by the Commissioner of the New Jersey Department of Environmental Protection to the Endangered and Non-Game Species Advisory Committee. Barbara is active with her alma mater, serving on the Campaign Cabinet at Montclair State University, in addition to chairing this board. She has a B.A. in Biology from Montclair State University and a Ph.D. in Biological Sciences from New York University.
Dr. John Anthes
Director, Thomas O. Daniel Research Incubator and Collaboration Center
Prior to joining Celgene, John was a Director of Biomedical Licensing at Rutgers University. In this role, he was responsible for evaluation and commercialization of the intellectual property of key Rutgers faculty. This included patenting, licensing, research contracts and NewCo activities. In addition, he was engaged in corporate outreach and liaison with University technology transfer offices throughout the country. Before Rutgers, John was a Director of External Scientific Affairs at Merck, involved with coordinating and driving decisions of due diligence teams regarding in‐licensing opportunities. Prior to the acquisition by Merck, John was a Research Fellow at Schering‐ Plough, involved with the preclinical pharmacological characterization of several clinical candidates including commercial products Claritin, Clarinex, Nasonex and Dulera.
Dr. Michel M. Bitritto
EVP, Business Development, Retired
The EcoShelf Group
Dr. Michel M. Bitritto is a creative and accomplished science and technology business expert with over 25 years of experience in business development, marketing, R&D, entrepreneurship, management and government. Recently retired, Michel has been able to devote more time to pursuits she enjoys. She is a published author of personal, non-fiction essays and is having a lot of fun with it. Additionally, she provides guidance and mentorship to Montclair State students at various career skill workshops.
Dr. John F. Bonamo
Executive Vice President and Chief Medical and Quality Officer
Dr. John F. Bonamo, is a physician executive with a distinguished clinical background in obstetrics and gynecology and hospital leadership. Dr. Bonamo earned his M.D. from the University of Medicine and Dentistry of New Jersey. He completed an internship and residency in Obstetrics and Gynecology at Saint Barnabas Medical Center in 1981, and immediately joined the medical staff at Saint Barnabas. Dr. Bonamo is board certified by the American Board of Obstetrics and Gynecology. From 1981 through 1999, he had a busy private practice in West Orange, New Jersey and was a highly respected obstetrician and gynecologist. In January 2000, he left private practice to assume the administrative position of Senior Vice President for Medical Affairs at Saint Barnabas Medical Center. He served in that position until April 2001, at which time he was appointed President and Chief Executive Officer. Building on his experience as a physician and as an administrator, Dr. Bonamo enrolled in the Harvard School of Public Health at Harvard University, and in 2003 earned a degree of Master of Science in Health Care Management. He now serves as an adjunct lecturer in the Health Policy and Management Department in the School of Public Health, as well as a visiting Professor at the University of Beijing masters’ program for hospital management. Dr. Bonamo is a Fellow of the American College of Healthcare Executives, of the American Board of Obstetricians and Gynecologists and is a member of the New Jersey Obstetrical and Gynecological Society.
Mr. Ronald M. Califre ’72 ’08 HON
SVP and Head, U.S. Operations, Retired
R&D, Novartis Pharmaceuticals Corp.
Vice Chair, Advisory Board
Mr. Ron Califre started his career with the U.S. Food and Drug Administration, where he worked for ten years in positions of increasing responsibility. He then joined Ciba-Geigy in Regulatory Affairs, eventually heading that function before being promoted to Sr. V.P., Medicine and Clinical Development, U.S. In that capacity, he was responsible for all aspects of drug development and medical and regulatory affairs, as well as heading the global neuroscience review board. At the time of the merger with Sandoz to form Novartis, Ron was appointed Sr. V.P., Drug Development. He later assumed responsibility for the discovery research functions, becoming Sr. V. P. of Research and Development, overseeing the activities of approximately 2,400 people in drug discovery, pre-clinical research, early development, technical development, clinical development, drug safety and regulatory affairs in the U.S. He was a member of the Research Management Board and the Development Leadership Team and served on the boards of several companies and non-profit organizations. Following his retirement from Novartis, he has remained active on the advisory boards of several universities as well as engaging in independent consulting. After graduating from Montclair in 1972, Ron has done graduate work in pharmacy, pharmacology and food and drug law.
Mr. Mario M. Casabona
Founder and Managing Partner
Casabona Ventures, LLC
Mr. Mario M. Casabona is an entrepreneur and active angel investor. In 2012, he founded TechLaunch, committed to identifying and nurturing early-stage tech ventures by mentoring, coaching and providing access to resources and capital. To date, TechLaunch has supported over 50 tech companies and mentored over 100 aspiring entrepreneurs. In 2006, he founded Casabona Ventures, investing in over 30 seed and early stage companies. In 1982, he founded Electro-Radiation Inc., which was acquired by Honeywell International in 2004. He received the Small Business Administration National Tibbett’s Award for his contributions in technology and was listed as one of the top five most influential persons in New Jersey technology by The Star-Ledger. He was twice recognized by the New Jersey Technology Council, first as the recipient of their Legend of Technology Award and subsequently their Financier of the Year Award. He is Chairman Emeritus of Jumpstart NJ Angel Network and Chairman Emeritus of the R&D Council of New Jersey. He also enjoys serving on the boards of various for-profit and not-for-profit organizations. Mr. Casabona is an electrical engineer and holds twelve national and international patents in the field of satellite-based navigation and communications.
Dr. Francis M. Cuss
EVP and CSO, R&D, Retired
Bristol-Myers Squibb Company
Vice Chair, Montclair State University Board of Trustees
Dr. Francis M. Cuss is a physician-scientist, with a background in general and academic medicine, and a broad experience in pharmaceutical research, in clinical development and in executive management within globally-operating biopharma companies during a career of more than 30 years in the pharmaceutical industry, specifically with Bristol Myers Squibb (BMS), Schering-Plough (now Merck) and Glaxo. Francis retired from Bristol-Myers Squibb in July 2017 having served as Executive Vice President and Chief Scientific Officer since July 2013 and as a member of BMS’s Senior Management Team since 2010. He joined Bristol-Myers Squibb in 2003 and, as head of Research for nearly a decade, Francis led a very productive discovery organization which produced an innovative pipeline from both in-house and external programs, helping numerous patients prevail against serious disease and laying the foundation for the generation of significant company growth and value. He is a member of the board of directors of Novo Holdings A/S, Denmark, Rubius Therapeutics, Cambridge MA and Vice Chair of the Board of Trustees of Montclair State University. Prior to joining the pharmaceutical industry, Francis was a practicing physician with a specialization in pulmonary medicine in the U.K. He received his education and medical training in the United Kingdom, receiving medical degrees from Cambridge University, U.K. and is a fellow of the Royal College of Physicians and the Faculty of Pharmaceutical Medicine. He has published numerous articles and book chapters on topics of medical interest.
Mr. Terence J. Gunning ’79
President and CEO
Lone Oak Business Solution
Mr. Gunning has 30 years of management experience in the healthcare industry including diagnostic testing and services, medical devices and consumer healthcare products. Prior to Lone Oak Business Solutions, a life sciences consulting firm, Terry was CEO of Cadent, a worldwide medical service and device start-up headquartered in Carlstadt, New Jersey. Terry’s tenure as Cadent’s CEO brought a tripling of revenue and significant improvement in operating profit and cash flow concurrent with several successful capital funding campaigns which paved the way for a successful strategic exit. As President of Datascope’s Cardiac Assist Division (CA) Terry brought significant sales increases, the launch of three new products, CA’s first successful acquisition and re-establishment of CA as the worldwide leader in counter-pulsation therapy. As Vice President and Head of the Corporate Anatomic Pathology Division, and as Vice President, Marketing, for Quest Diagnostics, he led several growth initiatives resulting in significant top- and bottom-line improvements. His resume includes marketing-related senior management positions with Johnson & Johnson Consumer Products and Bristol-Myers Squibb. Terry earned his M.B.A. in Finance and Accounting at Columbia University and B.S. in Chemistry at Montclair State University. Terry and his wife Kathy have been married 28 years and are the proud parents of four children. They reside in Basking Ridge, NJ.
Ms. Rachael N. Jones ’99
Vice President, Growth and Business Development
Anthem Diversified Business Group
Rachael Jones oversees the management and growth of client relationships within Anthem’s Diversified Business Group, a division delivering market-leading solutions that drive reductions in cost of care and improve clinical outcomes. She leads a team that leverages the commercial experience of Anthem, the nation’s largest Blue health plan, bringing strategic solutions to health plans across the country. Focusing on a range of health plan needs, these solutions offer critical insights on how to personalize and integrate care for those with complex and chronic conditions.
Mr. Merwin Kinkade, CHMM, REM ’80 MA
Founder and Vice President
Mr. Merwin Kinkade established Viridian® Inc. Environmental Consultants in 1991, and incorporated in 1992, to provide services to lending institutions, realtors, attorneys, municipalities, and commercial and industrial clients. His areas of expertise include environmental site assessments (Transaction Screens, Phases I, II, and III), Preliminary Assessments, Site Investigations, Remedial Investigations, Remedial Action Workplans and Remedial Action Reports, underground storage tanks, Industrial Site Recovery Act (ISRA) investigation and remediation, hazardous materials assessments, site plan review for Planning and Zoning Boards and municipal environmental consulting. Before forming Viridian, Kinkade was a principal and environmental group director for a mid-size engineering consulting firm, and regional manager for a national environmental contractor. He was an adjunct faculty at NJ Institute of Technology from 1970 until 1993, teaching courses related to ecology, environment, energy and technology. Mr. Kinkade has attained various certifications and trainings, and served on a number of planning boards, environmental commissions and non-profit boards in leadership roles. Mr. Kinkade earned a B.S. in Business Administration at Babson College, an M.A. In Personnel Administration at NYU and an M.A. in Environmental Studies at Montclair State University.
Mr. Mark Koehne
Senior Vice President and Actuary
Mutual of America Life Insurance Company
Since 2003, Mr. Mark Koehne has been responsible for leading the 23 member Actuarial Consulting Services Department, which provides actuarial valuations and other services required for the ongoing funding and administration of defined benefit plans sponsored by over 125 clients. The department also provides design and compliance services to defined contribution type plans. Mr. Koehne has over 40 years of experience in the valuation and design of defined benefit and defined contribution plans and has spent over 30 years working specifically with plans of not-for-profit employers, including multiple employer plans. Most recently, he has spearheaded the company’s successful re-entry into the pension risk transfer space. Mr. Koehne began his career with Mutual of America in 1975. Prior to rejoining the firm in 1996, Mr. Koehne was employed as a Vice President with Alexander & Alexander for 10 years, working with a number of Fortune 500 clients and other nationally recognized firms. He graduated from the College of Insurance with a Bachelor of Science degree in Actuarial Sciences. Mr. Koehne is an Enrolled Actuary and a member of the American Academy of Actuaries. He is a member of the Pension Board for the Archdiocese of Newark, where he also chairs the Investment Committee, the Pension Board of the Diocese of Metuchen and the New York State Actuarial Advisory Committee.
Mr. Anthony J. Matarazzo ’94 MS
Senior Director, Water Quality and Environmental Management
New Jersey American Water
Mr. Anthony Matarazzo has been a leader at New Jersey American Water since 2003. He has been actively involved in collaborations with various faculty at Montclair State including the Passaic River Institute and is passionate about providing career-building jobs opportunities for the next generation of science students. Anthony hosted a PSEG ISS Green Team, a member of which graduated with a B.S./M.S. in Environmental Studies. Anthony is a proud alumnus of Montclair State University where he earned his M.S. in Environmental Management in 1994. Prior to that, he earned a bachelor’s degree at Rutgers, majoring in biology and chemistry. He enjoys travel and is an avid fisherman.
Ms. Twinkle Morgan
Cooperman College Scholars
Twinkle Morgan is the founding Executive Director of the Cooperman College Scholars, a scholarship program targeting academically talented students who are traditionally underrepresented in higher education. Morgan has a passion for the issues surrounding college access for underserved communities, and because of this passion, she also developed, designed and implemented The Fellowship Initiative (TFI), a JPMorgan Chase & Co. program to expand academic and professional opportunities for young men of color. As founding Executive Director of TFI, she established TFI’s New York operations in 2010 before its replication across three other US regions in 2014. Prior to this role, Morgan served as the founding Director of Development with Uncommon Schools, a nationally recognized charter management organization that seek to close the achievement gap and prepare underrepresented students to graduate from college. Morgan served as Director of Development for just under five years, raising more than $27 million in private and public grants. From 2000 to 2005, she was a Vice President Relationship Manager with JPMorgan Private Bank. Before working on Wall Street, Morgan worked with Accenture for three years as a Strategy Consultant. Her work in the early years of her career included developing pre-college programs for the National Association of Black Engineers (NSBE) and college support services at Georgia Tech’s Office of Minority Educational Development (OMED). A native of Louisiana, she completed a B.S. in Mathematics from Spelman College in 1995 and a B.S. in Industrial Engineering from the Georgia Institute of Technology in 1996 as a National Aeronautics and Space Administration (NASA) Scholar, supporting Johnson Space Center’s flight simulation team. Morgan earned an M.B.A. from the Wharton Business School in 2001.
Dr. Marc Morresi ’99
Summit Medical Group
Dr. Marc Morresi is an Internist at Summit Medical Group. He brings a wealth of experiences to a practice in Bloomfield, the town where he grew up, along with a lifelong ambition to be a caring, compassionate physician. Prior to joining SMG in 2016, Marc developed and ran Morresi Medical Associates from 2011.
Ms. Linda J. Obenauer-Kutner ’80 ’83 MA
Senior Research Scientist II
Bristol-Myers Squibb Company
Ms. Linda J. Obenauer-Kutner is a scientist and a cancer survivor, Linda is a passionate supporter of science advocacy and giving back to the community. Linda has been a pharmaceutical industry professional for over 25 years. As an analytical CMC lead at Bristol-Myers Squibb, she has been a significant contributor to the initial filing of Opdivo, an immuno-oncology treatment for different cancer types. She continues contributing towards formulation development in a senior research scientist role in R&D. She joined BMS in 2006 from Schering-Plough Research Institute (now Merck). Linda supports outreach efforts through her association with organizations like the Association for Women in Science (AWIS) and is a core team member of the BMS Adoption Community Network (ACN). As the treasurer of AWIS New Jersey, a multi-disciplinary organization for women in science, technology, engineering and mathematics (STEM), she volunteers her time to support initiatives promoting policies that increase women representation and leadership positions by fostering a positive public image of women in STEM. Linda holds a Bachelor of Science and a Master of Arts degree in Biology from Montclair State University. She has numerous publications in peer-reviewed journals.
Ms. Meme Omogbai
President & CEO
Meme Omogbai & Associates
Ms. Meme Omogbai was named one of 25 Influential Black Women in Business by The Network Journal in 2010, Ms. Omogbai has been a leader in the nonprofit, corporate, museum and government sectors. As the first American of African descent named Board Chair of the American Alliance of Museums (AAM), Ms. Omogbai co-authored its ground-breaking strategic plan, The Spark, and led the initiative to rebrand the AAM as a global alliance. As Co-Director, Interim CEO, COO, CFO and Trustee, she led a major transformation in operating performance at the 105-year-old Newark Museum. Her program of financial accountability and innovation propelled the organization to the pinnacle of achievement with four consecutive years of 4-star Guide Star ratings for superior management. Ms. Omogbai’s background includes serving as the first minority, and youngest, Deputy Assistant Chancellor of New Jersey’s Department of Higher Education. Her multifaceted experience includes expertise in finance and management with the New Jersey Casino Control Commission, and former Big 8 global accounting firm Arthur Young & Co. She currently serves as a Director on the board of the AAM, the Advisory Board of St. Vincent Academy, as well as our own. She has been appointed by the Emir of Borgu Kingdom and Emirate to the Think Tank on the cultural infrastructure of the Emirate and establishment of its monuments and history. She is the Immediate Past Chair of New Jersey Historic Trust, after previously serving two years as Chair and two as Vice Chair.
Mr. Robert Pollock
Sr. Director Environmental Projects and Permitting
Public Service Electric and Gas Company (PSE&G)
Mr. Pollock brings biological and regulatory permitting, as well as management experience acquired within the utility, private development, and public sectors. He served as the owner of Environmental Resource Consulting, LLC for seven years upon which a utility focus was developed in identifying environmental regulatory requirements and ultimately delivering agency approvals. Currently, as Senior Director, he directs a group of 23 associates responsible for preparing and implementing high level strategies necessary for obtaining regulatory approvals for approximately $2 billion in capital infrastructure projects annually.
Ms. Sandra Powell-Elliot
Vice President, Life Sciences and Innovation
Hackensack Meridian Health
Sandra Powell Elliott’s role at Hackensack Meridian Health is not only to foster the internal development of an innovative culture, but to bring innovative and transformative solutions from outside of the organization to the forefront of the organization’s strategic planning efforts. The scope of internal and external innovation spans the breadth of precision medicine, new device development, new product and solution development, new business model development, remote models of care and population health management, as well as more efficient ways to operate the business units within an integrated health network. She has been instrumental in defining opportunities to work with innovative companies and begin to understand how home or person based technology can be integrated into a health delivery system alongside automation to transform how clinical care can be provided at the bedside. In addition, Sandra is intimately involved in the development of the new Center for Discovery and Innovation, a translational research enterprise focused on infectious disease, cancer, and regenerative medicine based on the campus of the new Hackensack Meridian Health School of Medicine in Nutley. Sandra received the 2018 NJBIZ Vanguard Award, speaks at National Conferences and has published many articles on developing opportunities for growing business in publications such as: Trustee Magazine, Journal of Healthcare Financial Management, FutureAge, Hospitals and Health Networks, and Health Strategist.
Mr. Richard Russo
President and CEO
Mr. Richard Russo is a 30+ year Medtech veteran. He is currently CEO of Endomedix Inc., a start-up working with biopolymer chemistry to develop a hemostat for use in brain surgery. Prior to Endomedix, he was the CEO of a start-up that became the largest processor in Europe of human tissue for transplantation, OST Développement in Clermont-Ferrand, France. OST serviced customers throughout Europe, Latin America and Asia. He had previously helped successfully develop and commercialize devices using pulsed electromagnetic field and ultrasound technologies to stimulate bone formation. Functionally, he has worked in sales and marketing, clinical research, regulatory affairs and strategic planning, in addition to general management. Richard earned a B.A. cum laude in philosophy from Boston College before pursuing graduate studies in philosophy at the Université de Fribourg in Switzerland. Richard also earned an M.B.A. from Columbia Business School in NYC.
Dr. Anthony Scriffignano ’82 ’85 MS
Senior Vice President, Chief Data Scientist
Dun & Bradstreet
Anthony Scriffignano is an internationally recognized data scientist with experience spanning over 35 years in multiple industries and enterprise domains. He serves on various advisory committees in government, in the private sector, and in academia. He is considered an expert on emerging trends in advanced analytics, the Big Data explosion, artificial intelligence, multilingual challenges in business identity and malfeasance in commercial and public-sector contexts. His extensive background in anomaly detection, computational linguistics and advanced inferential algorithms, has led to being primary inventor on multiple patents globally. Dr. Scriffignano was named the U.S. Chief Data Officer of the Year in 2018 by the CDO Club; has briefed and counseled U.S. government committees and foreign governments, contributed to reports to the President on Big Data Analytics, the Strategic Vision of Emerging Technologies, and Internet and Communications Resilience; has presented as a panelist and keynote speaker at major world events including the World Internet Conference in China hosted by President Xi Jinping and the China Development Forum.
Mr. John Szabo ’88
Vice President, Head of Production Services Operations and Shared Technology
Mr. Szabo describes himself as a results-oriented IT executive with extensive experience planning and leading successful projects and teams while implementing, developing and supporting customer-focused technology and support. He is a PMI Agile Certified Practitioner (PMI-ACP) with over twenty years of experience in industries that focus on information technology, operations management, support services, and software/hardware development and deployment. He has over 17 years of project management experience in these areas, and over 10 years of resource and budget management experience in complex technology and software. He has also managed the equipment and service deployments of voice, data and optical networks in central office, customer premise and laboratory environments.
Ms. Ni’Kita Wilson ’99
Vice President, Sales and Innovation
Ms. Ni’Kita Wilson is an award-winning cosmetic chemistry expert who holds numerous patents, has authored chapters of books, speaks at industry conferences around the country, and has developed a number of skincare lines. Essence magazine recognized Ni’Kita as one of the premier Cosmetic Chemists in the beauty industry and featured her in the May 2013 issue of the magazine and on Essence.com. Prior to her role at Aware Products, she was Founder and CEO of Skinects LLC and Catalyst Cosmetic Development, she began in the industry with leadership roles in cosmetic labs. In her current role, Ni’Kita enjoys the unique position on both the creative and consumer sides of the beauty business. On the business end, she acts as a liaison between marketing and R&D to facilitate product launches or a partner to R&D to handle creative “overload” (too many projects but not enough time or staff). For the consumer, she offers insight on beauty products, answers questions about ingredients and debunks myths, new and old, that continually plague the industry. Ni’Kita is a member of the New York Chapter- Society of Cosmetic Chemists (SCC), an active member of Cosmetic Executive Women (CEW) and Fashion Group International.